Goldman Sachs’s Insulet PODD Stock Holding History

Goldman Sachs’s Portfolio PODD Stock Details PODD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-50,000	Closed	-$4.75M	–	5302
2019 Q1	$4.75M	Buy	+50,000	New	+$4.29M	﹤0.01%	3009
2018 Q4	–	Sell	-23,800	Closed	-$2.52M	–	5575
2018 Q3	$2.52M	Buy	+23,800	New	+$2.23M	﹤0.01%	3448
2016 Q2	–	Sell	-75,000	Closed	-$2.49M	–	7193
2016 Q1	$2.49M	Buy	75,000 +29,500	+65%	+$926K	﹤0.01%	3286
2015 Q4	$1.72M	Buy	+45,500	New	+$1.53M	﹤0.01%	3777
2015 Q3	–	Sell	-50,000	Closed	-$1.55M	–	7449
2015 Q2	$1.55M	Sell	50,000 -50,000	-50%	-$1.47M	﹤0.01%	4103
2015 Q1	$3.33M	Buy	100,000 +50,000	+100%	+$1.69M	﹤0.01%	3291
2014 Q4	$2.3M	Hold	50,000	–	–	﹤0.01%	3707
2014 Q3	$1.84M	Buy	+50,000	New	+$1.83M	﹤0.01%	4019
2014 Q1	–	Sell	-188,100	Closed	-$6.98M	–	6887
2013 Q4	$6.98M	Buy	+188,100	New	+$6.95M	﹤0.01%	2712

Other funds holding PODD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Goldman Sachs's PODD Position: Q2 2026 in Review

Goldman Sachs reduced its Insulet (PODD) stake by 5.3% in Q2 2026, selling an estimated $7.61M and leaving 818,265 shares worth $125M. The position accounts for 0.01% of the portfolio, ranked #1076.

Goldman Sachs first reported a position in PODD in Q2 2013 and has held it in 53 quarters since. The position peaked at $311M in Q2 2025. 731 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

Goldman Sachs held 818,265 shares of Insulet worth $125M as of Q2 2026.
Goldman Sachs sold 45,651 Insulet shares in Q2 2026, an estimated $7.61M.
Insulet made up 0.01% of Goldman Sachs's portfolio in Q2 2026, its #1076 holding.
Goldman Sachs first reported a position in Insulet in Q2 2013 and has held it in 53 quarters since.
Goldman Sachs's Insulet position peaked at $311M in Q2 2025.
731 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.